Growth Hormone / Recovery
CJC-1295 + Ipamorelin 5+5mg
CJC-1295 without DAC, co-lyophilised with Ipamorelin at 5mg of each. A short-acting GHRH analogue paired with a selective ghrelin-receptor agonist.
Vial size
Quantity
£129.47
£184.95
Save £55.48
In stockInc. VAT · Free UK shipping on this order
- Delivery.
- Free UK shipping on this order, Royal Mail Tracked 24. Same-day dispatch before 6pm. Details
- Payment.
- Card — including Apple Pay and Google Pay — or bank transfer approved in your banking app. We never see your card or bank details.
- Returns.
- 14 days to cancel if unopened and sealed (you pay return postage). Faulty, damaged or wrong items are replaced or refunded at our cost. Policy
Certificate of Analysis
CJC-1295 + Ipamorelin 5+5mg
- Independent lab
- an accredited independent laboratory
- Batch number
- —
- Method
- HPLC-UV + MS
- Result
- ≥98% HPLC (both peptides)
The CoA you download is the exact certificate produced for this lot — no edits.
Storage & handling
Keep it stable, keep it sterile
- Sealed vial
- -20°C, protect from light
- Once reconstituted
- Once reconstituted, store at 2–8°C (refrigerated). Use within 28 days. Do not refreeze after reconstitution.
- Diluent
- Bacteriostatic water (0.9% benzyl alcohol)
- Shipping
- Insulated, ice packs
About CJC-1295 + Ipamorelin
CJC-1295 is supplied here in its DAC-free form — CJC-1295 without DAC, also written Modified GRF (1-29): residues 1 to 29 of human growth-hormone-releasing hormone, C-terminally amidated, carrying four stabilising substitutions (D-Ala2, Gln8, Ala15, Leu27) of which the D-alanine at position 2 makes the peptide a non-substrate for DPP-4 and takes clearance from the minutes of native GHRH to roughly thirty. 3367.9 Da, CAS 863288-34-0. It is not the DAC form: that molecule is 3647.2 Da, carries a linker binding covalently to albumin at cysteine-34, acts over days, and is not stocked here. Ipamorelin is a 711.9 Da pentapeptide and a selective agonist at GHS-R1a, the ghrelin receptor — reported by Raun and colleagues in 1998 to release GH without the prolactin, ACTH and cortisol increases seen with earlier secretagogues such as GHRP-6. The two peptides act at separate receptors, and both are short-acting, so the pair is studied as one coordinated brief stimulus. That is a design rationale rather than a demonstrated result: no factorial study measuring each peptide alone and together has established synergy for this combination. Each vial contains 5mg CJC-1295 without DAC and 5mg Ipamorelin, co-lyophilised, with identity confirmed separately for each component and blend purity reported against a ≥98% specification on a signed batch Certificate of Analysis.
Research areas
- GHRH receptor (GHRHR) signalling
- GHS-R1a / ghrelin receptor agonism
- Somatotroph GH-pulse models
- IGF-1 axis signalling
- GHRH vs GHRP pathway comparison
Every batch independently tested by an accredited independent laboratory before dispatch. The signed certificate for this lot is published on this page.
Legal notice
This product is sold strictly for in-vitro laboratory research purposes only. It is not approved for human or veterinary use, is not a drug, food, or cosmetic, and should not be misused as such. UK Peptides accepts no liability for misuse. By purchasing you confirm you are a qualified researcher aged 18 or over.
CJC-1295 + Ipamorelin 5+5mg
£129.47